On March 31, 2022, tramadol was removed from the Prescription Drug List (PDL) and listed in Schedule I of the Controlled Drugs and Substances Act (CDSA). It was also listed as item 19 in the Schedule of the Narcotic Control Regulations (NCR). Therefore, tramadol is now subject to all the regulatory requirements set out in the CDSA and NCR.
Since March 31, the College has received a number of questions from registrants on the implications of this change on their practice. This article explores and provides clarity on some of the most common questions received by College staff.